| |
|
| ORIGINALARBEITEN
(Erstautorschaft) - Publikationsliste mit Impactfaktoren |
 |
T.
Maca, W. Mlekusch, L. Doweik, A. C. Budinsky, M.
Bischof, E. Minar, M. Schillinger.
INFLUENCE AND INTERACTION OF DIABETES AND LIPOPROTEIN
(a) SERUM LEVELS ON MORTALITY
OF PATIENTS WITH PERIPHERAL ARTERY DISEASE European
Journal of Clinical Investigation.
2007, 37(3):180-6. IF 2.847
|
T.H.
Maca, Schillinger M, Hamwi A, Mlekusch W, Sabeti
S, Wagner O, Minar E.
INSULIN, C-PEPTIDE, AND RESTENOSIS AFTER FEMORAL
ARTERY BALLOON ANGIOPLASTY
IN TYPE II DIABETIC AND NONDIABETIC PATIENTS.Journal
of Vascular Interventional
Radiology. 2008, 16(1):31-5. IF 1.68
|
T.H.
Maca, R.Ahmadi, K.Derfler, H. Ehringer, M.E. Gschwandtner,
W.H. Hörl, R.Katzenschlager,
E.Müller-Knespel, R. Koppensteiner, E. Minar,
B. Schneider, A.Stümpflen, A. Ugurluoglu, E.Minar.
INFLUENCE OF LIPOPROTEIN(a) ON RESTENOSIS AFTER
FEMOROPOPLITEAL PERCUTANEOUS
TRANSLUMINAL ANGIOPLASTY IN TYPE II DIABETIC PATIENTS.
CORRELATION TO RESTENOSIS
DESPITE LOWER LP(a) IN NIDDM. Diabetic Medicine
2002, 19 (4): 300-6. 2.73 |
Maca
Th, Ahmadi R, Derfler K, Hörl WH, Koppensteiner
R, Minar E, Schneider B, Stümpflen A,
Ehringer H.ELEVATED LIPOPROTEIN(a) INCREASES THE
INCIDENCE OF RESTENOSIS AFTER
FEMOROPOPLITEAL PTA. RATIONALE FOR THE HIGHER RISK
OF RECURRENCES IN FEMALES?
Atherosclerosis 1996; 127 (1): 27-34. 2.919
|
T.Maca,
P.Fasching, M.Rohac, M.Stur, B.Schneider und W.Waldhäusl.
SEKUNDÄRPRÄVENTION DER DIABETISCHEN RETINOPATHIE
BEI DIABETES MELLITUS TYP I:
ABHÄNGIGKEIT VOM RETINOPATHIESTATUS VOR DER
INTERVENTION.
Deutsche Medizinische Wochenschrift 1996; 121: 257-262.
0.681
|
auch
japanisch erschienen:
T.Maca, P.Fasching, M.Rohac, M.Stur, B.Schneider
und W.Waldhäusl.SECONDARY PREVENTION
OF DIABETIC RETINOPATHY IN TYPE I (IDDM) DIABETES
MELLITUS: DEPENDENCE ON
RETINOPATHY STATUS BEFORE INTERVENTION.D.M.W. Japan
Ltd. 1996; 18 (3): 323-328. (0.681)
|
|
|
| ORIGINALARBEITEN
(Coautorschaft) |
|
|
|
|
|
|
|
Giurgea
AG, Margeta C, Maca T, Rezaie-Majd A, Bucek RA,
Manavi M, Afarideh R, Minar E,
Baghestanian M.SIMVASTATIN REDUCES SERUM LEVEL OF
VASCULAR ENDOTHELIAL GROWTH
FACTOR IN HYPERCHOLESTEROLEMIC PATIENTS. 1.99
|
|
|
|
Luksch
A, Rainer G, Koyuncu D, Ehrlich P, Maca T, Gschwandtner
ME, Vass C, Schmetterer L.
EFFECT OF NIMODIPINE ON OCULAR BLOOD FLOW AND COLOUR
CONTRAST SENSITIVITY IN
PATIENTS WITH NORMAL TENSION GLAUCOMA.Br J Ophthalmol.
2008 Jan;89(1):21-5. 1.76
|
|
|
|
Al-Awami
M, Schillinger M, Maca T, Pollanz S, Minar E.
LOW LEVEL LASER THERAPY FOR TREATMENT OF PRIMARY
AND SECONDARY RAYNAUD'S
PHENOMENON.Vasa. 2004 Feb;33(1):25-9. 0.82
|
|
|
|
Doweik
L, Maca T, Schillinger M, Budinsky A, Sabeti S,
Minar E.FIBRINOGEN PREDICTS MORTALITY
IN HIGH RISK PATIENTS WITH PERIPHERAL ARTERY DISEASE.
Eur J Vasc Endovasc Surg. 2003 Oct;26(4):381-6.
1.68
|
|
|
|
Schwarz
C, Mitterbauer C, Boczula M, Maca T, Funovics M,
Heinze G, Lorenz M, Kovarik J,
Oberbauer R.FLOW MONITORING: PERFORMANCE CHARACTERISTICS
OF ULTRASOUND
DILUTION VERSUS COLOR DOPPLER ULTRASOUND COMPARED
WITH FISTULOGRAPHY.
Am J Kidney Dis. 2003 Sep;42(3):539-45. 3.61
|
|
|
|
Rezaie-Majd
A, Prager GW, Bucek RA, Schernthaner GH, Maca T,
Kress HG, Valent P,
Binder BR, Minar E and Baghestanian M. SIMVASTATIN
REDUCES THE EXPRESSION
OF ADHESION MOLECULES IN CIRCULATING MONOCYTES FROM
HYPERCHOLESTEROLEMIC
PATIENTS.Arterioscl Thromb Vasc Biol 2003 Mar;23(3):397-403.
5.11
|
|
|
|
Ziegler
S, Maca T, Alt E, Speiser W, Schneider B, Minar
E.MONITORING OF ANTIPLATELET
THERAPY WITH PFA-100®IN PERIPHERAL ANGIOPLASTY
PATIENTS.
Platelets 2002 Dec;13(8):493-7. 0.78
|
|
|
|
Schillinger
M, Mlekusch W, Haumer M, Sabeti S, Maca T, Minar
E.
RELATION OF SMALL ARTERY COMPLIANCE AND LIPOPROTEIN
(a) IN PATIENTS WITH
ATHEROSCLEROSIS.Am J Hypertens. 2002 Nov;15(11):980-5.
2.75
|
|
|
|
Mlekusch
W., Schillinger M., Sabeti S., Haumer M., Maca Th.,
Gschwandtner ME, Minar E.
OUTCOME OF CONSERVATIVE MEDICAL TREATMENT OF PATIENTS
WITH INFRARENAL ABDOMINAL
AORTIC ANEURYSMS.Wien Klin Wochenschr 2002,Nov.;114(21-22):898-903.
0.57
|
|
|
|
Funovics
MA, Lackner B, Cejna M, Peloschek P, Sailer J, Philipp
MO, Maca T, Ahmadi A, Minar E
and Lammer J.PREDICTORS OF LONG-TERM RESULTS AFTER
TREATMENT OF ILIAC ARTERY
OBLITERATION BY TRANSLUMINAL ANGIOPLASTY.Cardiovasc
Intervent Radiol
2002 Sep-Oct;25(5):397-402. 0.91 |
|
|
|
Mlekusch
W., Schillinger M., Sabeti S., Maca Th., Ahmadi
R., Minar E.
CLINICAL OUTCOME AND PROGNOSTIC FACTORS FOR ISCHEMIC
ULCERS TREATED WITH
PTA IN LOWER LIMBS. Eur J Vasc Endovasc Ther 2002
Aug;24(2):176-81. 1.56
|
|
|
|
A.
Rezaie-Majd, T. Maca, R. Bucek, P. Valent, M.R.
Müller, P. Husslein, A. Kashanipour, E. Minar
and
M. Baghstanian. SIMVASTATIN REDUCES EXPRESSION OF
CYTOKINES INTERLEUKIN-6,
INTERLEUKIN-8 AND MONOCYTE CHEMOATTRACTANT PROTEIN-1
IN CIRCULATING MONOCYTES
FROM HYPERCHOLESTEROLEMIC PATIENTS.Arterioscl Thromb
Vasc Biol 2002 Jul;22(7):1194-9. 5.11
|
|
|
Ahmadi
R, Schillinger M, Maca T, Minar E.
FEMOROPOPLITEAL ARTERIES: IMMEDIATE AND LONG-TERM
RESULTS WITH A DACRON-COVERED
STENT-GRAFT.Radiology. 2002 May; 223(2):345-50.
4.13
|
|
|
Ahmadi
R, Willfort A, Lang W, Schillinger M, Alt E, Gschwandtner
ME, Haumer M, Maca T, Ehringer H,
Minar E. CAROTID ARTERY STENTING: EFFECT OF LEARNING
CURVE AND INTERMEDIATE-TERM
MORPHOLOGICAL OUTCOME.J Endovasc Ther. 2001 Dec;
8(6):539-46. 4.33
|
|
|
Ahmadi
R, Willfort A, Lang W, Schillinger M, Alt E, Gschwandtner
ME, Haumer M, Maca T, Ehringer H,
Minar E. CAROTID ARTERY STENTING: EFFECT OF LEARNING
CURVE AND INTERMEDIATE-TERM
MORPHOLOGICAL OUTCOME.J Endovasc Ther. 2001 Dec;
8(6):539-46. 4.33
|
|
|
Ziegler
S, Schillinger M, Maca TH, Minar E.
POST-THROMBOTIC SYNDROME AFTER PRIMARY EVENT OF
DEEP VENOUS THROMBOSIS 10 TO 20
YEARS AGO.Thromb Res. 2001 Jan 15; 101(2): 23-33.
1.32
|
|
|
Bucek
RA, Schnurer G, Ahmadi A, Maca TH, Meissl G, Minar
E.
A SEVERE CASE OF VASCULAR THORACIC OUTLET SYNDROME.
Wien Klin Wochenschr. 2000 Nov 24; 112(22): 973-7.
0.57
|
|
|
Bucek
RA, Maca T, Ahmadi R, Minar E.
TEMPORARY VENA CAVA FILTERS DO NOT ALWAYS PROTECT
FROM FATAL PULMONARY EMBOLISM.
Vasa. 2000 Nov; 29(4): 292-4. 0.82
|
|
|
Bucek
RA, Maca T, Ahmadi R, Minar E.
TEMPORARY VENA CAVA FILTERS DO NOT ALWAYS PROTECT
FROM FATAL PULMONARY EMBOLISM.
Vasa. 2000 Nov; 29(4): 292-4. 0.82
|
|
|
Pokrajac
B, Potter R, Maca T, Fellner C, Mittlbock M, Ahmadi
R, Seitz W, Minar E.
INTRAARTERIAL (192)IR HIGH-DOSE-RATE BRACHYTHERAPY
FOR PROPHYLAXIS OF RESTENOSIS
AFTER FEMOROPOPLITEAL PERCUTANEOUS TRANSLUMINAL
ANGIOPLASTY: THE PROSPECTIVE
RANDOMIZED VIENNA-2-TRIAL RADIOTHERAPY PARAMETERS
AND RISK FACTORS ANALYSIS.
Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):
923-31. 3.05
|
|
|
A.
Stümpflen, A. Ahmadi, M. Atteneder, M. Gschwandtner,
S. Hofmann, T. Maca, G. Schnürer,
E. Minar.EFFECTS ON TRANSVENOUS REGIONAL GUANETHIDINE
BLOCK IN THE TREATMENT OF
CRITICAL FINGER ISCHEMIA.Angiology - Journal of
Vascular Diseases 2000 Feb;51(2): 115-22.
0.62
|
|
|
B.
Stoiser, T. Maca, F. Thalhammer, U. Hollenstein,
I. El-Menyawi, M. Burgmann.
SERUM NITRATE CONCENTRATIONS IN PATIENTS WITH PERIPHERAL
ARTERIAL OCCLUSIVE
DISEASE.VASA 1999; 28: 181-184 0.82
|
|
|
M.E.
Gschwandtner, E. Minar, A. Ahmadi, M. Haumer, M.
Hülsmann, T. Maca, G. Schnürer, A.
Willfort, P. Polterauer,G. Meissl, H. Ehringer.IMPACT
OF DIFFERENT THERAPEUTIC ALTERNATIVES
IN TREATMENT OF SEVERE LIMB ISCHEMIA: EXPERIENCES
ON 190 CONSECUTIVE PATIENTS AT A
DEPARTMENT OF MEDICAL ANGIOLOGY.VASA 1999; 28: 271-278.
0.82
|
|
|
E.
Minar, B. Pokrajac, R. Ahmadi, Th. Maca, H. Ehringer.BRACHYTHERAPY
FOR PROPHYLAXIS OF
RESTENOSIS AFTER LONG-SEGMENT FEMOROPOPLITEAL ANGIOPLASTY:
PILOT STUDY.Radiology
1998; 208: 173-179 4.13
|
|
|
Heinz
Burgmann, Apostolos Georgopoulos, Wolfgang Graninger,
Renate Koppensteiner,
Thomas Maca,Erich Minar,Barbara Schneider, Andreas
Stümpflen, Herbert Ehringer.TISSUE
CONCENTRATION OF ANTIBIOTICS NEAR ISCHEMIC ULCERS
IS MUCH HIGHER USING
TRANSVENOUS APPLICATION IN BIER'S ARTERIAL ARREST:
COMPARISON WITH INTRAVENOUS
AND INTRAARTERIAL APPLICATION OF CLINDAMYCIN AND
GENTAMICIN IN SYNOPSIS WITH THEIR
CORRESPONDING BLOOD CONCENTRATIONS.Lancet 1996;
348: 781-783. 15.94
|
|
H.Burgmann,
U.Hollenstein, T.Maca, K.Zedwitz-Liebenstein, F.Thalhammer,
R.Koppensteiner,
H.Ehringer,W.Graninger. INCREASED SERUM LAMININ
AND ANGIOGENIN CONCENTRATIONS IN
PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE.J
Clin Pathol 1996; 49: 1-3. 1.422
|
|
R.Katzenschlager,
A.Ahmadi, E.Minar, R.Koppensteiner, Th.Maca, K.Pikesch,
A.Stümpflen,
A.Ugurluoglu, H.Ehringer.FEMOROPOPLITEAL ARTERY:
INITIAL AND 6-MONTH RESULTS OF COLOR-
DUPLEX US-GUIDED PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY.
Radiology 1996; 199: 331-334. 4.13
|
|
|
|
M.E.Gschwandtner,
R.Koppensteiner, Th.Maca, E.Minar, B.Schneider,
G.Schnürer and Ehringer.
SPONTANEOUS LASER DOPPLER FLUX DISTRIBUTION IN ISCHEMIC
ULCERS AND THE EFFECTOF PROSTANOIDS: A CROSSOVER
STUDY COMPARING THE ACUTE ACTION OF PROSTAGLANDIN
E1 AND ILOPROST VS. SALINE.Microvascular Research
1996; 51: 29-38. 1.775
|
|
|
|
E.Minar,
A.Ahmadi, R.Koppensteiner, Th.Maca, A.Stümpflen,
A.Ugurluoglu, H.Ehringer.COMPARISON
BETWEEN HIGH-DOSE AND LOW-DOSE ASPIRIN ON RESTENOSIS
AFTER
FEMOROPOPLITEAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY.
Circulation 1995; 91: 2167-2173. 10.89
|
|
R.Katzenschlager,
A.Ugurluoglu, A.Ahmadi, M.Hülsmann, R.Koppensteiner,
E.Larch, Th.Maca,
E.Minar,A.Stümpflen,H.Ehringer.INCIDENCE OF
PSEUDOANEURYSM AFTER DIAGNOSTIC AND
THERAPEUTIC ANGIOGRAPHY.Radiology 1995; 195: 463-466.
4.13
|
|
M.Raderer,
Th.Maca, M.Hejna, G.Weinländer, J.Kastner,
G.Kornek, Th.Tetzner, W.Scheithauer.
TOXICITY PROFILE OF THE NOVEL CHEMOSENSITIZER DEXVERAPAMIL.
Onkologie 1995; 18: 462-467. 0.380
|
P.Fasching,
K.Derfler, Th.Maca, S.Kurzemann, K.Howorka, B.Schneider,
M.Zirm, W.Waldhäusl.
FEASIBILITY AND EFFICACY OF INTENSIVE INSULIN THERAPY
IN TYPE I DIABETES MELLITUS
IN PRIMARY CARE.Diabetic Medicine 1994; 11: 836-842.
2.73
|
|
| |
|
|
|
|
BUCHBEITRAG
Diabetes in der Praxis; W.Waldhäusl, F.A.Gries
(Hrsg.), Springer-Verlag 1993. Kapitel: Arterielle
Verschlußkrankheit bei Diabetes Mellitus;
H. Ehringer, R. Koppensteiner,
T. Maca. S.370-393.
|
K.Derfler,
M.M.Hirschl, P.Fasching, Th.Maca, G.Heinz, W.Waldhäusl.PROGNOSE
VON TYPI-/
TYPII-DIABETIKERN MIT TERMINALER NIERENINSUFFIZIENZ
BZW. UNTER NIERENERSATZTHERAPIE.Diabetes und Stoffwechsel
1992; 1: 212-217.
|
|
|
|
|
|
|
